Russian defence ministry, Archive in Podolsk, Russia

London, Sep 4 A Russian Covid-19 vaccine has shown no serious side effects and elicited an immune response in early human trials, said a study published in The Lancet on Friday.Russia last month registered the "Sputnik V", becoming the first country to approve a Covid-19 vaccine.However, the country faced criticism for approving a vaccine before completion of Phase-3 trials.According to the study, published in The Lancet, the researchers enrolled 76 healthy adult volunteers (aged 18-60 years) for the two Phase-1 and Phase-2 studies 38 people in each study.In Phase-1 of the study, two groups of nine volunteers received one dose of either recombinant adenovirus type 26 (rAd26) vector or recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for SARS-CoV-2 spike glycoprotein (rAd26-S and rAd5-S), in frozen form.In Phase-2, another group of 20 healthy adult volunteers in each study received sequential doses of rAd26-S followed by rAd5-S of one of the two formulations.Adverse events were mostly mild, with the most common adverse events being pain at the injection site, hyperthermia, headache, asthenia, and muscle and joint pain, said the study.Both formulations of the vaccine were immunogenic in all participants, inducing neutralising humoral and cell-mediated responses, said the study.In Phase-2, 85 per cent of participants had detectable antibodies at 14 days after the priming dose, rising to 100 per cent by day 21, the results showed."The two 42-day trials - including 38 healthy adults each - did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response," the study's authors wrote.The study's authors also held that large, long-term trials, including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing Covid-19 infection.Reports suggest that Russia is planning a Phase-3 trial of the vaccine involving 40,000 people.( With inputs from IANS )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Russian Defence MinistryFOLLOW

Russian defence ministry, Latest News

Moscow, Sep 17 Russia registered 5,762 new Covid-19 cases in the past 24 hours, taking its total number ... ...

Moscow, Sep 13 Russ on Sunday headed to polling stations to cast their ballots in the local elections, ... ...

New Delhi, Sep 12 As organisations opt to use open-source operating systems worldwide, cybersecurity researchers have warned that ... ...

The Foreign Ministers of Russia, India, China exchanged views on further strengthening of Russia-India-China trilateral cooperation as well as topical issues of international and regional importance, according to a Joint Press Release. ...

The Foreign Ministers of Russia and India held discussions on cooperation in nuclear and space sectors and agreed to work closely in UNSC during India's forthcoming tenure as non-permanent member, Ministry of External Affairs (MEA) said on Thursday. ...

External Affairs Minister S Jaishankar on Tuesday landed in Moscow for Shanghai Cooperation Organisation (SCO) Foreign Ministers' meet. ...

The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliv ...

London, Sep 4 A Russian Covid-19 vaccine has shown no serious side effects and elicited an immune response ... ...